Narrative review: Furosemide for hypercalcemia: An unproven yet common practice

Annals of Internal Medicine

Volumn 149, Issue 4, 2008, Pages 259-263

  LeGrand, Susan B ^a   Leskuski, Dona ^b   Zama, Ivan ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID; FUROSEMIDE; IBANDRONIC ACID; PAMIDRONIC ACID; PYROPHOSPHATE; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; LOOP DIURETIC AGENT; ORAL REHYDRATION SOLUTION; SODIUM CHLORIDE;

CALCIUM EXCRETION; CLINICAL PRACTICE; CLINICAL TRIAL; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LOW DRUG DOSE; MEDICAL RESEARCH; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; DRUG COMBINATION; FLUID THERAPY;

CALCITONIN; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; FLUID THERAPY; FUROSEMIDE; HUMANS; HYPERCALCEMIA; REHYDRATION SOLUTIONS; SODIUM CHLORIDE; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 49849095031     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-149-4-200808190-00007     Document Type: Review

References (49)

1. Suki WN, Yium JJ, Von Minden M, Saller-Hebert C, Eknoyan G, Martinez-Maldonado M. Acute treatment of hypercalcemia with furosemide. N Engl J Med. 1970;283:836-40. [PMID: 5458033]
2. Fillastre JP, Humbert G, Leroy J. Treatment of acute hypercalcemia with furosemide. Curr Ther Res Clin Exp. 1973;15:641-9. [PMID: 4201547]
3. Helzberg J, Pinnick R, Grantham JJ. Refractory hypercalcemia. Management with intravenous fluids and furosemide guided by Swan-Ganz monitoring. J Kans Med Soc. 1983;84:16-7, 40. [PMID: 6827171]
4. Latos DL, Valentine AM. Treatment of hypercalcemia with furosemide and corticosteroids. W V Med J. 1973;69:52-4. [PMID: 4510163]
5. Caron C. [Treatment of hypercalcemia using furosemide]. Union Med Can. 1975;104:272-5. [PMID: 1162763]
6. Baguet JC, Rampon S, Bussière JL, Sauvezie B, Gontier Y, Flori B, et al. [Treatment of acute hypercalcemia with furosemide]. Rev Rhum Mal Osteoartic. 1972;39:531-5. [PMID: 5084224]
7. Le Gall JR, Raphaël JC, Offenstadt G, Marcel GA, Mignon F, Métreau JM, et al. [Treatment of a case of acute hypercalcemia with furosemide]. Ann Med Interne (Paris). 1971;122:613-7. [PMID: 5563715]
8. Humbert G, Fillastre JP, Leroy J, Robert M, Delaunay P. [Acute hypercalcemia. Treatment with furosemide]. Nouv Presse Med. 1972;1:2025-30. [PMID: 4678222]
9. Najjar SS, Aftimos SF, Kurani RF. Furosemide therapy for hypercalcemia in infants. J Pediatr. 1972;81:1171-4. [PMID: 4643038]
10. Zweig JI, Shafer N. Treatment of hypercalcemia with etidronate disodium [Letter]. JAMA. 1980;244:437-8. [PMID: 6771418]
11. Singer FR, Ritch PS, Lad TE, Ringenberg QS, Schiller JH, Recker RR, et al. Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group. Arch Intern Med. 1991;151:471-6. [PMID: 1900410]
12. Warrell RP Jr, Murphy WK, Schulman P, O'Dwyer PJ, Heller G. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol. 1991;9:1467-75. [PMID: 1906532]
13. Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19:558-67. [PMID: 11208851]
14. Saunders Y, Ross JR, Broadley KE, Edmonds PM, Patel S. Steering Group. Systematic review of bisphosphonates for hypercalcaemia of malignancy. Palliat Med. 2004;18:418-31. [PMID: 15332420]
15. Body JJ. Current and future directions in medical therapy: hypercalcemia. Cancer. 2000;88:3054-8. [PMID: 10898351]
16. Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med. 1997;103:134-45. [PMID: 9274897]
17. Pecherstorfer M, Brenner K, Zojer N. Current management strategies for hypercalcemia. Treat Endocrinol. 2003;2:273-92. [PMID: 15966562]
18. Tal A, Graves L. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism. South Med J. 1996;89:637-40. [PMID: 8638211]
19. Lee DC, Lee GY. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication. J Toxicol Clin Toxicol. 1998;36:719-21. [PMID: 9865241]
20. Alborzi F, Leibowitz AB. Immobilization hypercalcemia in critical illness following bariatric surgery. Obes Surg. 2002;12:871-3. [PMID: 12568198]
21. Peralta MC, Gordon DL. Immobilization-related hypercalcemia after renal failure in burn injury. Endocr Pract. 2002;8:213-6. [PMID: 12113635]
22. Massagli TL, Cardenas DD. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury. Arch Phys Med Rehabil. 1999;80:998-1000. [PMID: 10488998]
23. Kedlaya D, Brandstater ME, Lee JK. Immobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate. Arch Phys Med Rehabil. 1998;79:222-5. [PMID: 9474008]
24. Westphal SA. Disseminated coccidioidomycosis associated with hypercalcemia. Mayo Clin Proc. 1998;73:893-4. [PMID: 9737228]
25. Caldwell JW, Arsura EL, Kilgore WB, Reddy CM, Johnson RH. Hypercalcemia in patients with disseminated coccidioidomycosis. Am J Med Sci. 2004;327:15-8. [PMID: 14722391]
26. Cline, DM. Hypercalcemia. Emergency department care and disposition. In: Ma JO, Cline D, Tintinalli J, Kelen GD, Gabor DK, Stapczynski JS, eds. Emergency Medicine Manual. 6th ed. New York: McGraw-Hill; 2004:659-60.
27. Londner M, Hammer D, Kelen GD. Hypercalcemia. In: Tintanalli JE, Kelen GD, Stapczynski JS, eds. Tintanalli's Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York: McGraw-Hill; 2004:106.
28. Khosla S. Hypercalcemia and hypocalcemia. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JH, et al, eds. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008:285-7.
29. Fukagawa M, Kurokawa K, Papadakis MA. Fluid and electrolyte disorders. In: McPhee SJ, Papadakis MA, Tierney LM, eds. Current Medical Diagnosis and Treatment 2008. New York: McGraw-Hill; 2008.
30. Management of patients with fluid and electrolyte disturbances. In: Morgan GE Jr, Mikhail MS, Murray MJ, eds. Clinical Anesthesiology. 4th ed. New York: McGraw-Hill; 2006.
31. Topf JM, Rankin S, Murray P. Electrolyte disturbances in critical care. In: Hall JB, Schmidt GA, Wood LD, eds. Principles of Critical Care. 3rd ed. New York: McGraw-Hill; 2005:1161-99.
32. Fluids and electrolytes. In: Gomella LG, Haist SA, eds. Clinician's Pocket Reference. 11th ed. New York: McGraw-Hill; 2007.
33. Holt EH, Inzucchi SE. Diseases of calcium metabolism and metabolic bone disease. In: Dale DC, ed. ACP Medicine. Hamilton, Ontario, Canada: BC Decker; 2008:698-713.
34. Carlson RW. Oncologic emergencies. In: Dale DC, ed. ACP Medicine. Hamilton, Ontario, Canada: BC Decker; 2008:2425-36.
35. Wysolmerski JJ, Insogna KL. The parathyroid glands, hypercalcemia and hypocalcemia. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2007:1897-906.
36. Pollack MR, Yu ASL, Taylor EN. Disorders of calcium, magnesium, and phosphate balance. In: Brenner, BM, ed. Brenner & Rector's The Kidney. 8th ed. Philadelphia: Saunders Elsevier; 2008:588-611.
37. Gardner DG. Endocrine emergencies. In: Gardner DG, Shoback D, eds. Greenspan's Basic and Clinical Endocrinology. 8th ed. New York: McGraw-Hill; 2007:281-345.
38. Morton RA, Lipton A. Hypercalcemia. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical Oncology. 3rd ed. Philadelphia: Elsevier Churchill Livingstone; 2004:957-72.
39. Sambandam K, Vijayan A. Fluid and electrolyte management. In: Cooper DH, Krainik AJ, Lubner SJ, Reno HEL, eds. Washington Manual of Medical Therapeutics. 32nd ed. Philadelphia: Lippincott Williams and Wilkins; 2007.
40. Luce JA. Oncologic emergencies. In: Wachter RM, Godman L, Hollander H, eds. Hospital Medicine. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2005.
41. Agus ZS, Berensen JR. Treatment of hypercalcemia. UpToDate Online 16.1 2008. Accessed at www.uptodateonline.com on 28 May 2008.
42. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373-9. [PMID: 15673803]
43. Wisneski LA. Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int. 1990;46 Suppl:S26-30. [PMID: 2137363]
44. Sekine M, Takami H. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Oncol Rep. 1998;5:197-9. [PMID: 9458321]
45. Thiébaud D, Jacquet AF, Burckhardt P. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate. Arch Intern Med. 1990;150:2125-8. [PMID: 2222097]
46. Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 2003;64:281-9. [PMID: 12787420]
47. Chang JT, Green L, Beitz J. Renal failure with the use of zoledronic acid [Letter]. N Engl J Med. 2003;349:1676-9; discussion 1676-9. [PMID: 14573746]
48. Machado CE, Flombaum CD. Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol. 1996;45:175-9. [PMID: 8706358]
49. Henrich D, Hoffmann M, Uppenkamp M, Bergner R. Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports. Acta Haematol. 2006;116:165-72. [PMID: 17016034]